Introduction .
Statics.
Risk factors.
survival rate.
Staging , Grading.
Special investigations.
WHO Classification .
Most common Benign and Malignant salivary gland Tumors
Clinical presentation and prognosis.
Surgical Treatment .
Summary.
Salivary gland tumors account for 2% to 6.5% of all head and neck neoplasms, are more common in female with a peak incidence in their 60s and 70s, but can occur in all age groups.
The majority of neoplasms occur in the parotid, and pleomorphic adenoma is the most common benign tumor and mucoepidermoid carcinoma the most common malignant tumor.
Irregular margins, bony invasions, the presence of metastatic lymph nodes and perineural spread can all be signs of malignancy.
Necrosis can also characterize malignancy.
Benign tumors were more common than malignant ones.
The prevalent benign tumor was PA, and the prevalent malignant tumors were ACC and MEC.
The smaller the gland more likely that a mass is malignant.
Salivary gland tumours are a relatively rare and morphologically diverse group of lesions. So here are slides containing information about salivary gland tumours with images.
Salivary gland tumours are a relatively rare and morphologically diverse group of lesions. So here are slides containing information about salivary gland tumours with images.
New AJCC/UICC Staging System for Head & Neck, and Thyroid CancerHimanshu Soni
The AJCC/UICC staging system is a major tool in oncology, currently used worldwide for clinical,
pathological and recurrent disease staging. The objective of this presentation is to
describe the characteristics of the TNM staging system and review the changes made to head and neck
cancer staging in the most recent (8th) edition.
New AJCC/UICC Staging System for Head & Neck, and Thyroid CancerHimanshu Soni
The AJCC/UICC staging system is a major tool in oncology, currently used worldwide for clinical,
pathological and recurrent disease staging. The objective of this presentation is to
describe the characteristics of the TNM staging system and review the changes made to head and neck
cancer staging in the most recent (8th) edition.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. Contants
• Introduction .
Statics.
Risk factors.
survival rate.
• Staging , Grading.
• Special investigations.
• WHO Classification .
• Most common Benign and Malignant salivary gland Tumors
Clinical presentation and prognosis.
Surgical Treatment .
• Summary.
6/25/2022 2
3. Introduction
• Salivary gland tumors account for 2% to 6.5% of all head and neck
neoplasms, are more common in female with a peak incidence in
their 60s and 70s, but can occur in all age groups.
• The majority of neoplasms occur in the parotid, and pleomorphic
adenoma is the most common benign tumor and mucoepidermoid
carcinoma the most common malignant tumor.
6/25/2022 3
5. Statics
Cancer Research UK
American Cancer Society
Worldwide, an estimated 53,583 people were diagnosed with salivary gland cancer in 2020. is
However, Salivary gland cancer a very rare cancer.
About 720 people are diagnosed with salivary gland cancer in the UK every year.
It is slightly more common in women than men.
The number of people getting salivary cancer has remained stable in recent years.
In 2020, an estimated 22,778 people died from salivary gland cancer worldwide.
6/25/2022
Cancer Research UK
American Cncer Society 5
7. survival rate
• The 5-year survival rate for salivary gland cancer is 75%.
• Survival rates for people with this type of tumor vary depending on
the type and the extent, or stage, of the cancer.
• If cancer is located only in the salivary gland, the 5-year survival rate
is 94%.
• If the cancer has spread outside the salivary gland to nearby
structures or lymph nodes, the 5-year survival rate is 67%.
• If it is found after the cancer has spread to distant parts of the body,
the 5-year survival rate is 44%.
6/25/2022 7
8. Staging and grading
• Clinical staging, histologic type and grade, location, cranial nerve
involvement (facial nerve), and patients’ demo Graphics are among
the prognostic factors implicated in salivary gland malignancies.
• Clinical stage, particularly size, is the most critical factor of outcome
rather that the histologic grade with the exception of few tumors.
• Pathological staging (surgical staging).
• Clinical staging refer to (physical-biopsy-imaging).
6/25/2022 8
9. • T1 :2cm or less
• T2 :2 – 4cm
• T3 :4 – 6cm or extension
• T4 :>6cm or palsy or extension
Tumor (T): How large is the primary tumor? Where is it located?
Node (N): Has the tumor spread to the lymph nodes? If so, where and how
many?
Metastasis (M): Has the cancer spread to other parts of the body? If so,
where and how much?
6/25/2022 9
• American Joint Committee on Cancer (AJCC) TNM system,
which is based on 3 key pieces of information:
12. Stage III:
-Smaller tumors (T1, T2)
-spread to regional lymph nodes
(N1)
-no sign of metastasis (M0).
6/25/2022 12
13. Stage IV A:
- invasive tumor (T4a) or (T3) with
either
-no lymph node involvement (N0)
-or spread to only a single same-sided
lymph node (N1) or (N2)
-no metastasis (M0).
6/25/2022 13
14. Stage IV B:
-Any cancer (any T),
-more extensive spread to lymph
nodes (N2, N3),
-no metastasis (M0).
6/25/2022 14
15. Stage IV C:
Any cancer with distant
metastasis (any T, any N,
and M1).
6/25/2022 15
16. Grade (G)
• We compares the malignant tissue with healthy tissue.
• If the cancer looks similar to healthy tissue and has different cell
groupings, it is called “differentiated” or a “low-grade tumor.”
• If the cancerous tissue looks very different from healthy tissue, it is
called “poorly differentiated” or a “high-grade tumor.” (anaplastic
carcinoma, carcinoma ex-pleomorphic adenoma, etc.) The cancer’s
grade may help us to predict how quickly the cancer will spread.
6/25/2022 16
17. Spiro et al. 1989
6/25/2022 17
• The results were clearly better in patients with low-grade lesions; the
presence of a high-grade tumor had no significant impact on survival
unless the tumor was large (>4 cm in diameter).
• Such as rapid change in size, infiltration, metastasis. These are
currently incorporated into the present staging system of salivary
cancer.
18. special investigations
• Biopsy (TRU CUT)
• Ultrasound-guided needle biopsy FNAB, is the most commonly
employed diagnostic modality for assessment of the pathology
of salivary masses.
• Ultrasound( ultrasonography will establish if the mass related to
the salivary gland or lymph nodes
• Computed tomography CT scan
• Positron emission tomography PET scan
• Magnetic resonance imaging (MRI) better for soft tissue
contrast.
6/25/2022 18
23. Pleomorphic
Adenoma (PA)
• Is the most common benign tumor
• They are more common between the 40s and 50s
• Referred as mixed tumor :the tumor has three
components: an epithelial, myoepithelial cell, and
mesenchymal components.
• Parotid glands (85%) followed by minor salivary glands
(10%) and the submandibular glands (5%)
6/25/2022 23
25. Important Points
• Painless, slow growing, mobile masses. Not involving
facial nerve.
• A carcenoma arising in a peolmorphic adenoma is
referred as carcinoma ex pelomorohic adenoma or
malignant mixed tumor.
• Bad actor
• High recurrence rate becouse the failure to recognize it
is protusions from the main mass into the surroding
tissue at the time of surgery.
• Risk of seeding
6/25/2022 25
27. Warthin’s Tumor
• Accounts for 5% to 7% of epithelial salivary gland
neoplasms.
• Vast majority found in the parotid, with bilateral
involvement in 4% to 6% of the cases
• Old age
• Associated with cigarette smoking and radiation
• The clinical presentation is that of a doughy painless
mass often found in the tail of the parotid
6/25/2022 27
29. Treatment Of Benign
Parotid Tumor
• The traditional surgical approach to benign
parotid tumors is a superficial parotidectomy
(SP) and that for deep lobe tumors is a total
parotidectomyn( ).
• Modern modifications include partial
superficial parotidectomy and selective deep
lobe parotidectomy
6/25/2022 29
30. Treatment of Benign tumors of the
submandibular and minor salivary glands
• A submandibular gland adenoma should be removed in continuity with the gland.
• The situation to be avoided is an adenectomy for apparent sialoadenitis when
the lesion is a malignant tumor.
• Most present as rubbery lumps and the diagnosis can be established by FNAC or
ideally a dermatological punch biopsy.
6/25/2022 30
32. Mucoepidermoid Carcinoma
• Is the most common malignant salivary
gland tumor.
• This tumor makes up 10% of major gland
tumors (mostly parotid) and 20% of minor
gland tumors (mostly palatal).
(Mean age is 45 years.
6/25/2022 32
33. Mucoepidermoid Carcinoma
• Clinical feature Presentation is a
submucosal mass that may be painful
or ulcerated.
• The mass may appear to have a
bluish shade because of the mucous
Content within the lesion.
(B) Mucoepidermoid carcinoma of the palate with
ulceration.
A) Mucoepidermoid carcinoma of the palate. Note the
bluish color from mucin content.
6/25/2022 33
36. Treatment
• Low-grade lesions is wide surgical excision
with a margin of uninvolved normal tissue;
• High-grade lesions require more
aggressive surgical removal with surgical
margins and, possibly, local radiation
therapy.
• Low-grade lesions have a 95% 5-year
survival rate.
• High-grade lesions have less than a 40% 5-
year survival rate.
6/25/2022 36
37. Polymorphous low-grade adenocarcinoma
• The second most common salivary gland malignancy.
• This lesion was first described in 1983; before its
identification
• Many cases were likely Misdiagnosed as adenoid
cystic carcinoma. Due to overlapping histological
features
• The most common site is the junction of the hard
and soft palate
(Polymorphous adenocarcinoma)
6/25/2022 37
38. Polymorphous Low-grade
Adenocarcinoma
• Clinical feature These tumors present as
Slow-growing, asymptomatic masses that
may become ulcerated.
• The treatment of this tumor is wide
surgical excision, with a relatively high
recurrence rate of 14%.
6/25/2022 38
39. Adenoid cystic carcinoma
• Third most common intraoral salivary gland
malignancy a mean age of 53 years.
• Clinical feature slow-growing, nonulcerated
masses, with an associated chronic dull pain. And it
can be faster growth rate and higher rate of distant
metastasis.
• The treatment is wide surgical excision, followed, in
some cases, by radiation therapy.
• The prognosis is poor despite aggressive therapy.
6/25/2022 39
41. Treatment Malignant Parotid Tumors
• The object of treatment is to excise the tumor with an adequate rim
of normal tissue ,but this may not be possible because of the complex
anatomy of the parotid area and emphasizes the practical nature of
the 4 cm rule, as adequate surgical clearance of tumor is not possible
with large masses.
• It is for this reason that Adjuvant radiotherapy plays an important
part in the management of salivary gland cancer.
6/25/2022 41
42. Facial Nerve
• Wherever possible a functioning facial nerve should be retained except
if completely within the tumor. The traditional approach to a malignant
parotid tumor is a total parotidectomy.
• Occasionally parotid lesions may result in facial paralysis as a result of
neurotropism, similar to the polymorphous low-grade
adenocarcinoma, and facial nerve involvement
• In contrast if a facial nerve palsy is already present then a radical
parotidectomy is a logical option.
• If the facial nerve has to be resected, ideally it should be reconstructed
at the same operation.
6/25/2022
42
44. Treatment Of Submandibular Gland
• The literature demonstrates that submandibular gland cancers carry a
20% worse prognosis than malignant tumors in the parotid or mouth.
• Initially this was attributed to a higher incidence of adenoid cystic
carcinomas in the submandibular gland.
• However Spiro showed this not to be the case. An appropriate
oncological procedure as the primary procedure restores the survival
rate to that achieved in both the mouth and the parotid.
6/25/2022 44
45. Minor Salivary Gland Tumors
• Minor salivary gland cancers within the oral cavity are managed in the
same way as squamous cell carcinomas in the mouth.
6/25/2022 45
46. Summary
• Irregular margins, bony invasions, the presence of metastatic lymph nodes
and perineural spread can all be signs of malignancy.
• Necrosis can also characterize malignancy.
• Benign tumors were more common than malignant ones.
• The prevalent benign tumor was PA, and the prevalent malignant tumors
were ACC and MEC.
• The smaller the gland more likely that a mass is malignant.
6/25/2022 46
47. Studies
• Most of the information comes from retrospective studies and
isolated case reports.
• Also, most trials to date have been heterogeneous and have involved
small numbers of patients, so informed decision making is difficult.
6/25/2022 47
48. Referances
• Ghali, G.E., Larsen, P.E. and Waite, P.D. eds., 2004. Peterson's principles of oral and maxillofacial surgery (Vol. 1, p. 37). London: BC Decker.
• Hupp, J.R., Tucker, M.R. and Ellis, E., 2013. Contemporary Oral and maxillofacial surgery-E-book. Elsevier health sciences.
• Andersson, L., Kahnberg, K.E. and Pogrel, M.A. eds., 2012. Oral and maxillofacial surgery. John Wiley & Sons.
• Friedman, E.R. and Saindane, A.M., 2013. Pitfalls in the staging of cancer of the major salivary gland neoplasms. Neuroimaging Clinics, 23(1), pp.107-
122.
• Galdirs, T.M., Kappler, M., Reich, W. and Eckert, A.W., 2019. Current aspects of salivary gland tumors–a systematic review of the literature. GMS
Interdisciplinary plastic and reconstructive surgery DGPW, 8.
• Goyal, G., Mehdi, S.A. and Ganti, A.K., 2015. Salivary gland cancers: biology and systemic therapy. Oncology, 29(10), pp.773-773.
• Sama, S., Komiya, T., & Guddati, A. (2021). Advances in the Treatment of Mucoepidermoid Carcinoma. World Journal Of Oncology, 13(1), 1-7.
• Monga, S., Malik, J.N., Sharma, A.P. and , S., 2014. Diagnostic Dilemma of Polymorphous Low Grade Adenocarcinoma of Hard Palate. Journal of Case
Reports, 4(1), pp.91-94.
• Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021: 71: 209- 249. https://doi.org/10.3322/caac.21660
• https://www.cancerresearchuk.org/about-cancer/salivary-gland-cancer/risks-
causes#:~:text=About%20720%20people%20are%20diagnosed,remained%20stable%20in%20recent%20years.
• Spiro, R.H., 1986. Salivary neoplasms: overview of a 35‐year experience with 2,807 patients. Head & neck surgery, 8(3), pp.177-184.
6/25/2022 48
The proportion of malignant tumors is greater in the minor glands (with the exception of the sublingual gland)
mumps, flu, Coxsackie viruses, echovirus and cytomegalovirus
Most recent studies though have clearly demonstrated that clinical stage, particularly size, is the most critical factor of outcome rather that the histologic grade with the exception of few tumors.
As a rule, the lower the number, the less the cancer has spread.
N1 same side as the affected salivary gland and the lymph node is smaller than 3cm in size
N2 is divided into 3 sub groups:
N2an one node on the same side as the affected 3 and 6cm in size (between 1.2 and 2.4 inches)
N2b several lymph nodes on the same side all smaller than 6cm in size
N2c other side of the face or in lymph nodes on both sides all smaller than 6cm
N3 is divided into 2 sub groups:
N3a at least one lymph node which is bigger than 6cm in size
N3b cancer cells have broken through the outside covering of the lymph node
In general, the lower the tumor’s grade, the better the prognosis. (accinic cell, low-grade adenoid carcinoma, etc.).
Spiro focused on the relationship of size rather than grade to outcome
The last method of determining the biological nature of the tumor and the most reliable is assessment of the clinical features of aggression,
The latter has taken over from histological type and histological grading as the most important prognostic factor determining treatment.
Caution with malignant tumors should be
exercised because the positive predictive value of FNAB is
low.83 Under light microscopy, specific features are distinctive
enough for adequate diagnosis whereas immunohistochemical
analysis may be employed in more complex
cases.
PET stands for positron emission tomography. The PET scan uses a mildly radioactive drug to show up areas of your body where cells are more active than normal. It's used to help diagnose some conditions including cancer.
Pleomorphic adenoma generally presents as a slowly progressing swelling, nonsymptomatic, and not involving facial nerve.5 Although PA principally manifests in the parotid glands, it can also be located in hard palate and soft palate glands of saliva, upper lip, cheek, tongue, and floor of the mouth.
85% superfacial
T2 bright small circuscribed margin
Sometime will be irreglar margin
failure to recognize it is projection from the main mass into the surroding tissue at the time of surgery
Smoking = duct blocking = tumor
20% multifocal bilateral and
Can be solid
Can have cystic componant
A total parotidectomy (TP) accompanies tumors
deep to the facial nerve where the exposed branches
of the nerve are lifted to access the tumor.
With this additional stripping of the nerve comes an increased
risk of permanent and temporary nerve injury (SP
The commonest intraoral site for benign salivary gland tumors is the junction of the hard and soft palate.
if it is small it can be circumscribed but if large it will Infltrait the other tissues and also throgh images some time no need for histopathology
Ct can help to define the margines
Approximately 50% of these tumors occur in the parotid gland, whereas the other 50% occur in the minor glands of the palate.
CNV7 AND CNV3
Tumours less than 4cm (T1 & T2) generally do well regardless of histological type or grade